Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis-Reference-Cited by-同舟云学术

Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis

Published:2009-05-28 Issue:3 Volume:50 Page:772-780
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fujita Koji,Nozaki Yuichi,Wada Koichiro,Yoneda Masato,Fujimoto Yoko,Fujitake Mihoyo,Endo Hiroki,Takahashi Hirokazu,Inamori Masahiko,Kobayashi Noritoshi,Kirikoshi Hiroyuki,Kubota Kensuke,Saito Satoru,Nakajima Atsushi

Publisher

Wiley

Subject

Hepatology

Reference28 articles.

1. The epidemiology of nonalcoholic fatty liver disease: a global perspective;Lazo;Semin Liver Dis,2008

2. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future;Wieckowska;HEPATOLOGY,2007

3. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

4. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?;Farrell;J Gastroenterol Hepatol,2003

5. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man;Matthews;Diabetalogia,1985

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Remnant Cholesterol and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis;Metabolic Syndrome and Related Disorders;2024-08-19

2. The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease;Frontiers in Endocrinology;2024-08-08

3. 17-Beta-Hydroxysteroid Dehydrogenase 13 Loss of Function Does Not Confer Protection to Nonalcoholic Fatty Liver Disease in Indian Population;Journal of Clinical and Experimental Hepatology;2024-07

4. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein;Nature Communications;2024-06-06

5. Oligonucleotide therapies for nonalcoholic steatohepatitis;Molecular Therapy - Nucleic Acids;2024-06